MONTEREY, Calif., April 17 /PRNewswire/ -- An optimized PARI eFlow platform nebulizer will be delivering Alnylam's ALN-RSV01 in a Phase II human clinical trial that has begun enrolling patients.
BROOKLYN, NY—Altronix, a provider of low voltage power supplies and transmission solutions for the security industry, introduced its new enhanced eFlow power supply/chargers with 30- to 50 percent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results